机构：[1]Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Shanghai National Clinical Research Center for metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China[2]Department of Internal Medicine, The Second People’s Hospital of Yuhuan, Yuhuan, China[3]Department of Research, VoxelCloud, Shanghai, China[4]Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China[5]Department of Electrical Engineering, Shanghai Jiao Tong University, Shanghai, China[6]Department of Ophthalmology, The Third People’s Hospital of Datong, Datong, China[7]Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China[8]Department of Endocrinology and Metabolism, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology Luoyang City Clinical Research Center for Endocrinology and Metabolism, Luoyang, China[9]Department of Internal Medicine of Traditional Chinese Medicine, Sheyang Diabetes Hospital, Yancheng, China[10]Department of Endocrinology, The Second Affiliated Hospital Dalian Medical University, Dalian, China[11]Department of Endocrinology, Datong Coal Group Ltd. General Hospital, Datong, China[12]Department of Endocrine and Metabolic Diseases, The First People’s Hospital of Yunnan Province, Kunming, China云南省第一人民医院[13]Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China[14]Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China[15]Department of Endocrinology, Longkou People’s Hospital, Yantai, China[16]Department of Endocrinology, The Third Affiliated Hospital of Nanchang University, Nanchang, China[17]Department of Endocrinology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China[18]Department of Endocrinology and Metabolism, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu, China[19]Department of Endocrinology and Metabolism, Hebi Coal (group) Ltd. General Hospital, Hebi, China[20]Department of Endocrinology and Metabolism, People’s Hospital of Zhengzhou, Zhengzhou, China[21]Department of Computer Science, Computer Graphics & Vision Laboratory, University of California Los Angeles, Los Angeles, California, USA[22]Department of Research, VoxelCloud, Los Angeles, California, USA
This research was supported by grants from National Key R&D Program
of China (2016YFC0901200, 2018YFC1314800); Chinese Academy of Engineering
(2019-XZ-
42); the National Natural Science Foundation of China (81670797); the
Program for Shanghai Outstanding Medical Academic Leader (2019LJ07); the
Youth Program of Shanghai Municipal Health and Family Planning Commission
(20174Y0081) and the Yang Fan Project of Shanghai Science and Technology
Committee (19YF1442700).
第一作者机构：[1]Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Shanghai National Clinical Research Center for metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
通讯作者：
通讯机构：[3]Department of Research, VoxelCloud, Shanghai, China[5]Department of Electrical Engineering, Shanghai Jiao Tong University, Shanghai, China
推荐引用方式(GB/T 7714)：
Yifei Zhang,Juan Shi,Ying Peng,et al.Artificial intelligence-enabled screening for diabetic retinopathy: a real-world, multicenter and prospective study(Open Access)[J].BMJ OPEN DIABETES RESEARCH & CARE.2020,8(1):doi:10.1136/bmjdrc-2020-001596.
APA：
Yifei Zhang,Juan Shi,Ying Peng,Zhiyun Zhao,Qidong Zheng...&Weiqing Wang.(2020).Artificial intelligence-enabled screening for diabetic retinopathy: a real-world, multicenter and prospective study(Open Access).BMJ OPEN DIABETES RESEARCH & CARE,8,(1)
MLA：
Yifei Zhang,et al."Artificial intelligence-enabled screening for diabetic retinopathy: a real-world, multicenter and prospective study(Open Access)".BMJ OPEN DIABETES RESEARCH & CARE 8..1(2020)
